Cytokinetics, Inc. (CYTK)
62.64
+0.69
(+1.11%)
USD |
NASDAQ |
Oct 19, 13:59
Cytokinetics Cash from Operations (Annual) : -510.01M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -510.01M |
| December 31, 2024 | -395.89M |
| December 31, 2023 | -414.33M |
| December 31, 2022 | -299.52M |
| December 31, 2021 | -142.52M |
| December 31, 2020 | 8.943M |
| December 31, 2019 | -90.91M |
| December 31, 2018 | -101.22M |
| December 31, 2017 | -101.76M |
| December 31, 2016 | 36.98M |
| December 31, 2015 | 4.883M |
| December 31, 2014 | -44.84M |
| December 31, 2013 | -7.718M |
| Date | Value |
|---|---|
| December 31, 2012 | -33.44M |
| December 31, 2011 | -45.60M |
| December 31, 2010 | -44.83M |
| December 31, 2009 | 8.416M |
| December 31, 2008 | -61.33M |
| December 31, 2007 | -3.005M |
| December 31, 2006 | -47.17M |
| December 31, 2005 | -39.48M |
| December 31, 2004 | -34.03M |
| December 31, 2003 | -30.51M |
| December 31, 2002 | -22.30M |
| December 31, 2001 | -1.781M |
| December 31, 2000 | -11.37M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Bristol Myers Squibb Co. | 14.16B |
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| BioMarin Pharmaceutical, Inc. | 827.99M |
| Exelixis, Inc. | 884.27M |
| Ionis Pharmaceuticals, Inc. | -268.58M |